Canadian Biotech Generex To Bring Metformin Chewing Gum Into India
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Enthused by the recent launch of its oral insulin brand Oral-Recosulin in partnership with India's Shreya Life Sciences, Canadian biotech firm Generex is preparing to launch its metformin chewing gum in the Indian market. Metformin is one of the oldest diabetes drugs and forms the backbone of first line treatment for the disease
You may also be interested in...
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).